NEU 5.50% $16.15 neuren pharmaceuticals limited

Here are three relevant quotes from Jon in the webinar relating...

  1. 16 Posts.
    lightbulb Created with Sketch. 37
    Here are three relevant quotes from Jon in the webinar relating to Phase 3 trials. I've included time-stamped links so you can hear it from Jon's mouth, but I'd strongly recommend that people listen to the entire webinar as it contains a lot of valuable information.


    “There’s no doubt that if you can do it you ‘ll create huge amount of value compared to now…”

    https://youtu.be/hO6z4VoEs8k?si=K7bj1Ua74VnrFDu-&t=1783


    “Estimated cost, I’ve said publicly a number of times that I think for each indication I think between $50m and $150m US dollars is the right range per indication. We’ll hone that down once we have some certainty on the trial design”

    https://youtu.be/hO6z4VoEs8k?si=F0Pyk-2j7O4v-lP-&t=2081



    “I think with our financial position that Dabue has given us that we can comfortably fund two indications ourselves, probably not more, with the current financial resources… through Phase 3”

    https://youtu.be/hO6z4VoEs8k?si=-Qr45OhWVdT5hSAZ&t=2104

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$16.15
Change
-0.940(5.50%)
Mkt cap ! $2.064B
Open High Low Value Volume
$15.04 $16.33 $14.65 $25.91M 1.638M

Buyers (Bids)

No. Vol. Price($)
1 125 $16.15
 

Sellers (Offers)

Price($) Vol. No.
$16.20 1500 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.